WeVote
Log In

Bill

Bill

LD 2019

An Act To Amend The Laws Governing Licensure Of Wholesalers And Manufacturers Under The Maine Pharmacy Act

132nd Legislature (2025-2026) Introduced by Kristi Mathieson

Maine bill modifies pharmacy wholesaler and manufacturer licensing requirements, advancing toward passage with committee support.

Signed by Governor
#healthcareservices #pharmacies #wholesalersandmanufacturers
0
WeVote Research Nonpartisan
Bill Summary · LD 2019

Legislative bill overview

LD 2019 amends Maine's pharmacy licensing laws to modify requirements for wholesalers and manufacturers operating under the Maine Pharmacy Act. The bill has progressed through committee with an "Ought to Pass" recommendation and is advancing toward floor consideration. Specific amendments are not detailed in the available legislative record.

Why is this important

Pharmacy wholesaler and manufacturer licensing directly affects drug supply chains, product quality oversight, and public access to medications in Maine. Changes to licensure requirements can impact operational costs for pharmaceutical businesses, regulatory compliance burdens, and ultimately consumer access to affordable medications.

Potential points of contention

  • Industry compliance costs: Depending on whether requirements are relaxed or tightened, businesses may face increased licensing expenses or reduced barriers to entry, creating competitive concerns
  • Public safety vs. deregulation: Changes must balance streamlined licensing with ensuring wholesalers/manufacturers maintain adequate quality and safety standards
  • Small business impact: Modifications could disproportionately affect smaller pharmaceutical operations versus large corporations, raising equity questions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.